RET and non-small cell lung carcinoma: Activating mutations in RET, however, are known to be oncogenic in medullary thyroid cancer (MTC) [3], making this RET-altered tumour different than papillary thyroid cancer or non-small-cell lung carcinoma (NSCLC).